Blocknomi
Key Highlights Shares of TNGX climbed 45% following announcement of a 92% objective response rate in pancreatic cancer patients treated with vopimetostat combined with daraxonrasib All 12 evaluable patients achieved…
Related articles
-
Following token-dumping scandal, Movement seeks new life as a Layer 1
The Block Published 02.06.2026 13:00
-
Bitcoin hit bottom at $59,000 marking end to the crypto winter, says Standard Chartered analyst
CoinDesk Published 12.06.2026 18:09
-
SpaceX Officially Joins Public Bitcoin Leaderboard as 8th Largest Holder With 18,712 BTC
Bitcoin Magazine Published 12.06.2026 15:45
-
Financial Advisors Pivot to Stablecoins and Tokenization: Bitcoin Takes the Back Seat
Crypto Daily Published 11.06.2026 10:21
-
Bitcoin (BTC) Plunges to $65K as Strategy Sells, ETF Outflows Continue
Blocknomi Published 03.06.2026 06:57
-
Franklin Templeton and MoonPay open new door for BENJI fund
Crypto.News Published 02.06.2026 17:13
-
S&P 500 Chases Historic Rally as Crude Surges on U.S.-Iran Conflict
Blocknomi Published 03.06.2026 12:05
-
Bitmine buys $52M ETH as Tom Lee says price not yet showing Ethereum’s strength
Cointelegraph Published 02.06.2026 04:03